We support Member States’ commitment to promote R&D to detect, prevent, test, and treat climate-sensitive diseases through the Climate Change and Health resolution and support the reiteration of this commitment in the Global Plan of Action.

Inadequate investment in R&D for climate-sensitive infectious diseases, including many NTDs, threatens the world’s ability to adapt to climate change. Development, availability, and equitable access to medicines, diagnostics, and vaccines is vital for adaptation and building resilient health systems.

To operationalize the commitment, we ask Member States to support development of a list of region-specific yet globally relevant climate-sensitive diseases, promote research on the links between climate change and NTDs, invest in R&D for new tools to tackle infectious diseases, and support the development of indicators on climate-sensitive diseases as part of the 14th GPW, GpoA, and Global Goal on Adaptation.